NEWS

Pharmaceutical Industry news helps our clients to give competitive edge to their customers and also latest pharmaceutical industry news assists them in gaining updated knowledge. We bring you Global Pharmaceutical news about acquisitions, project undertakings, business and marketing, subjects, and industry related subjects, written in a professional, unbiased and thought-provoking format. Our international pharmaceutical News will help you enhance your business knowledge and productivity.

news

Ritter Pharmaceuticals announces Phase 3 plans after its end of Phase 2 meeting with FDA on RP-G28 for lactose intolerance. Has incorporated guidance from FDA on key elements of its phase 3 program to support a new drug application (NDA) for RP-G28. Company anticipates initiating phase 3 program during first…

news

QPharma, a premier provider of compliance and commercial services to the life sciences industry, is expanding its footprint with the opening of a new office in the Somerset area of New Jersey. This centrally located location will enable the company to better serve its growing roster of pharmaceutical, medical device,…

news

The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's rare blood cancer drug, Besponsa, with a boxed warning. Besponsa was approved to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Based on the typical duration of treatment, the total cost of…

news

L.E.A.F. Pharmaceuticals LLC, a global pharmaceutical company located in the historic area of Valley Forge, Pennsylvania, USA, with a mission to discover, develop and commercialize innovative and safe therapies for cancer, today announced the establishment of L.E.A.F. Rwanda Ltd. (L.E.A.F. Rwanda), a biotechnology company, headquartered in Kigali, Rwanda.    L.E.A.F.…

news

Novo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the stage for it to become the new standard therapy for type 2 diabetes. The 40-week trial tested two dosages of Novo's once-weekly drug, semaglutide,…

news

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with Aduro Biotech Inc , to discover novel small molecule leads for multiple therapeutic targets of interest to Aduro. According to the agreement, HitGen will use its advanced technology platform, based on DNA-encoded library (DEL) design, synthesis…

news

Alvogen announced today that it has signed a definitive agreement to acquire Omega Bittner, a Russia-based pharmaceutical firm owned by Perrigo Company plc. Working with well-established and recognized brands in Russia including LactacydTM, AflubinTM and ParanitTM, the firm focuses on a targeted portfolio of over-the-counter drugs in categories such as…

news

Asymchem Laboratories Tianjin Co Ltd Says it signed an investment framework agreement with local government of Dunhua city, regarding green pharmaceutical key technology industrialization project. Says the total investment of the project is 600 million yuan.   Source: reuters.com

news

A unit of China's Fosun Group and Shanghai Pharmaceuticals Holding Co (601607.SS) are among bidders for a stake in U.S. speciality drugmaker Arbor Pharmaceuticals LLC, the companies said on Monday. The bids come as Chinese companies face tightening scrutiny on their overseas investments. Chinese regulators are reviewing deal agreements in…

news

Acella Pharmaceuticals, LLC, a leading U.S. manufacturer of specialty pharmaceuticals across several therapeutic categories, today announced an exclusive, multi-year, multi-product development and licensing partnership with Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, to develop, manufacture, and…

loadmore..